“As the global leader in rapid diagnostics for infectious disease, we commend the President for establishing a national strategy to address the serious threat of antibiotic resistance. We look forward to continuing to work with the Administration on initiatives to promote the development of rapid point-of-care tests that, in turn, help reduce the misuse of antibiotics and unnecessary health care spending,” said Avi Pelossof, Alere Global President, Infectious Disease.
The Executive Order signed by the President directs Federal departments and agencies to implement a new national strategy to combat antibiotic-resistant bacteria and to address recommendations in a report by the President’s Council of Advisors on Science and Technology (PCAST).
For more information on the Executive Order, go to http://www.whitehouse.gov/the-press-office/2014/09/18/executive-order-combating-antibiotic-resistant-bacteria
The companies, websites, products and services, and brands referenced and linked to/from this website are not sponsored or endorsed by, or otherwise affiliated with, Abbott or TestTargetTreat.com. The third-party products and services referenced and linked to/ from this website are included for informational purposes only, and have not been tested or approved by Abbott or TestTargetTreat.com. Neither Abbott nor TestTargetTreat.com makes any representations or warranties regarding third-party products or services, and shall not be liable for any claims arising from those products or services or your use thereof.
Measuring the Impact of Antimicrobial Stewardship in Healthcare Settings
The problem of antibiotic resistance
